Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
President and COO · Adaptive Biotechnologies Corp · Common Stock
Open-market sale
$58K reported value · 0.5% of prior position
Disclosed 0 business days after execution (deadline: 2)
Routine: 68 prior trades recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $253K 8,381 sh | Nov 10, 2026 traded Nov 9, 2026 | |
| 4 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $293K 9,981 sh | Nov 10, 2026 traded Nov 10, 2026 | |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 10, 2026 traded Nov 10, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 10, 2026 traded Nov 9, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $73K 2,400 sh | Nov 10, 2026 traded Nov 9, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 10, 2026 traded Nov 10, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 10, 2026 traded Nov 9, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $32K 1,100 sh | Nov 10, 2026 traded Nov 9, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $210K 7,881 sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $97K 3,481 sh | Nov 6, 2026 traded Nov 6, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $229K 8,400 sh | Nov 6, 2026 traded Nov 6, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 6, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $14K 500 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $103K 4,000 sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 1 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $147K 5,455 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 6, 2026 | |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $57,779
Rubinstein Julie filed this Form 4 reporting a open-market sale of ADPT on Nov 10, 2026. It became public on Nov 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.